Pharmacodynamics and tolerability of repository corticotropin injection in healthy human subjects: A comparison with intravenous methylprednisolone-Reference-Cited by-同舟云学术

Pharmacodynamics and tolerability of repository corticotropin injection in healthy human subjects: A comparison with intravenous methylprednisolone

Published:2015-09-10 Issue:2 Volume:56 Page:195-202
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Lal Ritu¹,Bell Stacie¹,Challenger Rashida¹,Hammock Vakessa¹,Nyberg Mary¹,Decker Dima¹,Becker Patrice M.¹,Young David¹

Affiliation:

1. Mallinckrodt PharmaceuticalsEllicott CityMDUSA

Funder

Mallinckrodt Pharmaceuticals

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.582

Reference23 articles.

1. Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs. placebo final report

2. Hypothalamo-pituitary-adrenal function in patients on long-term adrenocorticotrophin therapy.

3. The effect of adrenocorticotropic hormone (ACTH) and cortisone on the course of disseminated lupus erythematosus and peri‐arteritis nodosa;Carey RA;Bull Johns Hopkins Hosp.,1950

4. Observations on the Use of Cortisone and ACTH in Rheumatoid Arthritis

5. Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Narrative Review of Acthar Gel for the Treatment of Myositis;Rheumatology and Therapy;2023-03-26

2. Metabolic adverse events associated with systemic corticosteroid therapy—a systematic review and meta-analysis;BMJ Open;2022-12

3. Evaluation of liver injury in multiple sclerosis patients receiving pulsed steroid therapy;Multiple Sclerosis and Related Disorders;2022-09

4. Results from a multicenter, randomized, double‐blind, placebo‐controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids;CNS Neuroscience & Therapeutics;2022-01-04

5. Corticotrophins, corticosteroids, and prostaglandins;Side Effects of Drugs Annual;2021